Brain white-matter hyperintensities and treatment outcome in major depressive disorder

65Citations
Citations of this article
96Readers
Mendeley users who have this article in their library.

Abstract

Background: An increased incidence of brain white-matter hyperintensities has been described in major depressive disorder, but the impact of such hyperintensities on treatment outcome is still controversial. Aims: To investigate the relationship of brain white-matter hyperintensities with cardiovascular risk factors and with treatment outcome in younger people with major depressive disorder. Method: We assessed brain white-matter hyperintensities and cardiovascular risk factors in 84 people with major depressive disorder prior to initiating antidepressant treatment. We also assessed hyperintensities in 35 matched controls. Results: We found no significant difference in the prevalence of white-matter hyperintensities between the depression and the control groups. Left-hemisphere subcortical hyperintensities correlated with lower rates of treatment response. We found no correlation between global hyperintensity measures and clinical outcome. Brain white-matter hyperintensities correlated with hypertension and age and with total cardiovascular risk score. Conclusions: Subcortical white-matter hyperintensities inthe left hemisphere (but not in other brain areas) may be associated with poor response to antidepressant treatment in major depression.

Cite

CITATION STYLE

APA

Iosifescu, D. V., Renshaw, P. F., Lyoo, I. K., Lee, H. K., Perlis, R. H., Papakostas, G. I., … Fava, M. (2006). Brain white-matter hyperintensities and treatment outcome in major depressive disorder. British Journal of Psychiatry, 188(FEB.), 180–185. https://doi.org/10.1192/bjp.188.2.180

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free